Your fact-checks will appear here
Clinical research on the effectiveness of penile traction devices in reducing curvature in Peyronie's disease and increasing penile length
Randomized trials of modern penile traction therapy (), especially , show consistent, statistically and clinically meaningful improvements in penile length and curvature at 3 months and through short-...
Randomized and nonrandomized clinical trials of penile traction therapy (PTT) have tested several devices and protocols—most prominently the RestoreX device—in men with Peyronie’s disease and in the p...
Long‑term use of penile traction devices (PTDs) is generally reported as well tolerated, with most studies documenting mild, transient side effects such as discomfort, swelling, skin irritation, bruis...
A small set of traction and implant products are commonly marketed for penile stretching or aesthetic enhancement, and several vendors explicitly claim FDA clearance or approval—most notably SizeGenet...
Contemporary evidence shows two clusters of effective penile traction therapy (PTT) protocols: older-generation devices that required multi-hour daily wear (commonly ≥3–5 hours/day for several months)...
No randomized head‑to‑head trials comparing the penile traction device directly against other specific penile traction devices were identified in the provided reporting; published randomized studies o...
Independent, peer‑reviewed reports that reproduce outcomes appear confined to the original randomized and open‑label trials and closely linked follow‑ups led by investigators connected to the device’s...
Randomized controlled trials of penile traction devices () are limited but growing: the most-cited RCTs evaluate the RestoreX device in men with (n=110, randomized 3:1) and a separate randomized trial...
Randomized trials have mostly tested newer-generation penile traction devices (notably RestoreX and Penimaster PRO) against no‑intervention controls and have also explored shorter daily wear times (30...